APA (7th ed.) Citation

Xue Xu, Guifang Qin, Zudong Meng, & Dan Pei. (2021). Body mass index, disease duration and tumor necrosis factor inhibitor history predict reduced ustekinumab response in Chinese psoriasis patients: A real-world study. Wolters Kluwer Medknow Publications.

Chicago Style (17th ed.) Citation

Xue Xu, Guifang Qin, Zudong Meng, and Dan Pei. Body Mass Index, Disease Duration and Tumor Necrosis Factor Inhibitor History Predict Reduced Ustekinumab Response in Chinese Psoriasis Patients: A Real-world Study. Wolters Kluwer Medknow Publications, 2021.

MLA (9th ed.) Citation

Xue Xu, et al. Body Mass Index, Disease Duration and Tumor Necrosis Factor Inhibitor History Predict Reduced Ustekinumab Response in Chinese Psoriasis Patients: A Real-world Study. Wolters Kluwer Medknow Publications, 2021.